BSc, MBBS, MPH&TM, Dermatology Research Fellow, The Skin Hospital, Sydney, NSW.
MBBS, FACD, Consultant Dermatologist, The Skin Hospital, Sydney, NSW.
Aust J Gen Pract. 2021 Dec;50(12):880-885. doi: 10.31128/AJGP-05-21-6002.
Melasma is a common disorder of hyperpigmentation of the skin, characterised by brown pigmentation primarily on the face. Given its frequent facial involvement, it has a significant impact on the quality of life of patients. Management can often be quite difficult, requiring extensive treatment periods and multiple modalities for ongoing maintenance.
The aim of this article is to provide evidence-based clinical updates to clinicians, specifically general practitioners, to assist with their everyday practice and effective assessment and treatment of melasma.
Therapeutic modalities are chosen on the basis of disease presentation, patient preference, treatment periods and side-effect profiles of treatment agents; often a combination of therapies is required.
黄褐斑是一种常见的皮肤色素沉着过度疾病,特征是主要在面部出现棕色色素沉着。由于其频繁的面部受累,它对患者的生活质量有重大影响。治疗通常相当困难,需要广泛的治疗期和多种维持方式。
本文旨在为临床医生,特别是全科医生提供循证临床更新,以协助他们日常实践和对黄褐斑的有效评估和治疗。
治疗方式的选择基于疾病表现、患者偏好、治疗期和治疗药物的副作用特征;通常需要联合治疗。